Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Targeting HIV-Related Neurocognitive Impairments with Cognitive Training Strategies: Insights from the Cognitive Aging Literature 2021-01-01
  2. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment 2016-05-31

Studies

2 studies carry this tag.

Date range

2016 to 2021

Top journals

  • Current topics in behavioral neurosciences 1
  • Journal of neurovirology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Targeting HIV-Related Neurocognitive Impairments with Cognitive Training Strategies: Insights from the Cognitive Aging Literature

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Current topics in behavioral neurosciences 2021-01-01 Cognitive tests and assessment

    Approximately 50% of older adults with HIV meet the Frascati diagnostic criteria of HIV-associated neurocognitive disorders (HAND) which can interfere with everyday function such as medication adherence, employment, and driving ability, thus reducing quality of life.

  2. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurovirology 2016-05-31 Cognitive tests and assessment

    Given the high prevalence of HIV-associated neurocognitive disorders (HAND), we examined the performance of a novel computerized cognitive assessment device (NCAD) for the evaluation of neurocognitive impairment in the setting of HIV.

All topic tags with their study counts